📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA) (2020)

First Author: Collyer B

Attributed to: MRC Centre for Global Infectious Disease Analysis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pntd.0008644

PubMed Identifier: 33044958

Publication URI: http://europepmc.org/abstract/MED/33044958

Type: Journal Article/Review

Parent Publication: PLOS Neglected Tropical Diseases

Issue: 10

ISSN: 1935-2727